James Kent named Willis Re Global Deputy CEO LONDON, Nov.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
James Kent named Willis Re Global Deputy CEO

LONDON, Nov. 28, 2016 (GLOBE NEWSWIRE) -- Willis Re, the reinsurance business of leading global advisory, broking and solutions company Willis Towers Watson (NASDAQ: WLTW ), today announced the promotion of James Kent – Co-President of Willis Re and President of Willis Re North America – to the position of Global Deputy CEO, Willis Re, with immediate effect.

A long-standing member of Willis Re’s global leadership team, Kent will retain his role as President of Willis Re North America and continue to work in New York alongside Willis Re North America CEO, Jim Bradshaw, to drive sales and growth efforts, produce business and maintain market and client relationships in the region, which has seen 50 percent market share growth over the past five years and now represents Willis Re’s largest business segment.

In his additional capacity as Global Deputy CEO, Kent will work closely with Global CEO, John Cavanagh, and Global Chairman, Paddy Jago, to lead global business production, client and market relationship management and to drive the business’s operations worldwide.

Commenting on Kent’s promotion, John Cavanagh said: “James is one of the most highly regarded executives in the industry and has a stellar track record of driving innovation and financial performance. He is a well-respected leader within this business and has played a significant role in shaping Willis Re over the past decade, particularly in driving the growth of our Bermuda and North America operations. He is absolutely the right person to help further Willis Re’s global development and I look forward to working with him more closely in his new capacity as Deputy CEO.”

Carl Hess, Head of Willis Towers Watson’s Investment, Risk and Reinsurance segment, added: “James’ appointment reflects the deep strength of Willis Re’s leadership team and the strong track record within that team of product innovation and financial performance. Under John Cavanagh, Paddy Jago and the rest of the Willis Re leadership team, Willis Re’s development as a highly collaborative and client-focused business within the investment, risk and reinsurance arena continues to set it apart in the marketplace.”

Kent said: “Willis Re is a fantastic business and I very much look forward to working more closely with Paddy, John and the rest of the Willis Re leadership team in a global capacity to take this business forward.

“I will maintain my very strong ties and working relationships within North America, but having been part of the Willis Re global leadership team now for the past six years, my new role will enable me to further the already close relationships with my International and Specialty colleagues as we continue to build our client-focused business as part of Willis Towers Watson.”

Additional notes: Kent joined Willis Re in 2004 as Executive Vice President, Willis Re Bermuda, bringing more than 15 years’ experience producing and placing Property and Casualty treaty business across both London and Bermuda.

Following a successful tenure leading Willis Re’s Bermuda office, in 2010, Kent was appointed President of Willis Re North America, moving to New York to work alongside Willis Re North America CEO, Jim Bradshaw, and Willis Re North America Chairman, Paddy Jago.

He was appointed to the additional role of Co-President, Willis Re, in August 2015.

ABOUT WILLIS RE One of the world's leading reinsurance brokers, Willis Re is known for its world-class analytics capabilities, which it combines with its reinsurance expertise in a seamless, integrated offering that can help clients increase the value of their businesses. Willis Re serves the risk management and risk transfer needs of a diverse, global client base that includes all of the world's top insurance and reinsurance carriers as well as national catastrophe schemes in many countries around the world. The broker's global team of experts offers services and advice that can help clients make better reinsurance decisions and negotiate optimum terms. For more information, visit willisre.com .

ABOUT WILLIS TOWERS WATSON Willis Towers Watson (NASDAQ: WLTW ) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 39,000 employees in more than 120 territories. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.

CONTACT MEDIA Annie Roberts: +44 20 3124 7080 | Annie.Roberts@willistowerswatson.com INVESTORS Aida Sukys: +1 703 258 8033 | Aida.Sukys@willistowerswatson.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 43

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

CompoSecure's Adam Lowe Executes $490K Stock Sale and Insights

Updated Category News Views 302

Adam Lowe's Notable Stock Transactions Revealed Adam Lowe, the Chief Product & Innovation Officer at CompoSecure, Inc. (NASDAQ: CMPO), has recently stirred up some buzz following his stock sales, which amounted to over $490,000. According to recent regulatory filings, on a pivotal day, Lowe sold 40,658 shares of CompoSecure's Class A Common Stock, netting him $490,335...

Continue Reading
Extendicare Reports Strong Q4 and Year-End Results with Dividend Boost

Updated Category News Views 299

Extendicare's Positive Financial Performance in Q4 2024 Extendicare Inc. (TSX: EXE) has released its results for the last quarter of 2024, showcasing significant growth and a successful year overall. The company, known for its commitment to quality care for seniors across Canada, reported a remarkable increase in adjusted EBITDA, a key indicator of financial performance,...

Continue Reading
The Kayon's New Villas: Ubud's Intimate Luxury Retreat

Updated Category News Views 10

Embracing Exclusive Escapes in Ubud A couple of days ago, The Kayon Resort decided to stir the pot in Ubud's luxury accommodation landscape by rolling out two swanky villa categories: the Premier Pool Villa and the Royal Jacuzzi Pool Villa. No pandering here, just straight-up elegance mingling with nature. Why Ubud's Going Gaga Over Privacy People are craving privacy and...

Continue Reading
Exploring the Vibrant Growth of the Outdoor Backpacks Market

Updated Category News Views 147

The Outdoor Backpacks Market Growth Story The Outdoor Backpacks Market is experiencing remarkable growth, expected to increase by USD 997.1 million between 2025 and 2029. This growth reflects a projected CAGR of approximately 5.4%, driven primarily by rising interest in hiking among millennials. Today's outdoor enthusiasts are not just looking for gear; they desire...

Continue Reading
Nuveen Closed-End Funds Share Updated Distribution Notices

Updated Category News Views 79

Nuveen stirred the pot back in 2024 with a fresh drop on their closed-end funds (CEFs), rolling out distribution notices that laid bare the guts of their quarterly payouts. Yeah, those notices were packed with juicy details about where investors' cash was coming from—like net investment income and capital gains—but they also signaled some unsettling shifts lurking...

Continue Reading